Sumner Michael John (CIK 1936799) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy INO (9,450 shares), Sell INO (2,693 shares), Buy INO (2,385 shares), Sell INO (680 shares), Buy INO (5,010 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 9,450 | $0 |
| 2026-05-21 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Sell | 2,693 | $3,312 |
| 2026-05-18 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 2,385 | $0 |
| 2026-05-18 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Sell | 680 | $884 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 5,010 | $0 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 11,550 | $0 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Sell | 3,903 | $6,986 |
| 2025-07-01 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 2,916 | $0 |
| 2025-05-16 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 2,385 | $0 |
| 2025-05-16 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Sell | 680 | $1,326 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Medical Officer | Buy | 5,010 | $0 |
Source: SEC Form 4 filings · as of 2026-05-21